Vinca alkaloids. Experimental and clinical trials.
D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D002699:Chlorambucil / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007109:Immunity / Q000187:drug effects; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009420:Nervous System / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D014747:Vinblastine / Q000494:pharmacology / Q000627:therapeutic use*; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use*; D009396:Wilms Tumor / Q000188:drug therapy
D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine; D011241:Prednisone